FeesSafety
Pluang+

Ethereum options open interest rises to $6.27B, with calls dominating volume and positions

Technical Signals
24 Oct 2026
Tokenpost
View Source
Neutral
Ethereum options open interest rises to $6.27B, with calls dominating volume and positions

Ethereum options open interest increased by 3.75% to $6.27 billion, driven mainly by call options which accounted for over 63% of both open interest and daily trading volume. The most active contracts include Bybit's October 25 $2,750 call and Deribit's December 25 $3,200 call. This trend shows a strong preference for call options, indicating investor interest in leveraged exposure or hedging strategies, though it does not necessarily imply a bullish market outlook. Monitoring open interest and volume helps understand market sentiment and trading activity in Ethereum derivatives.

Ethereum options open interest reached $6.27 billion, with $2,750 calls leading volume. For readers following cryptocurrency markets, here is Pluang's snapshot as of Oct 24, 2026 17:51 WIB: out of 50 major cryptocurrencies, only 5 rose while 43 fell. EOS gained 8.13% to Rp12,649, contrasting with BAT which dropped 8.76% to Rp2,874 and ONE which fell 7.43% to Rp24 with a dominant 97% buy order activity on Pluang.

More News

Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix announced positive Phase 1 trial results for JNJ-1900 (NBTXR3), used with radiotherapy and immune checkpoint inhibitors, in 24 heavily pretreated advanced melanoma patients resistant to anti-PD-1 therapies. The treatment showed a 41.7% obj...

Company Fundamentals
Bullish
45 minutes ago
Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte announced a Phase 1/2 clinical trial to test a combination of petosemtamab, INCB161734, and standard chemotherapy as a first-line treatment for metastatic colorectal cancer with the KRAS G12D mutation. This mutation is common and li...

Company Fundamentals
Bullish
45 minutes ago
AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker has introduced a comprehensive Business Class Flight Routes Guide to help travelers from the US explore premium flight options to 15 major international destinations across Asia, Europe, Africa, and Australia. The guide covers airlines, ...

Others
Neutral
2 hours ago
Ethereum co-founder predicts AI and crypto will merge to enable trusted automated work on blockchain.

Ethereum co-founder predicts AI and crypto will merge to enable trusted automated work on blockchain.

Joseph Lubin, co-founder of Ethereum, predicts that artificial intelligence (AI) and cryptocurrency will merge on the Ethereum blockchain to create a system where automated tasks are commissioned, completed, and paid for with trust guaranteed by bloc...

Protocol Fundamentals
Bullish
4 hours ago
Bitcoin dips near $80K amid lower trading volume and rising exchange reserves, signaling cautious market sentiment.

Bitcoin dips near $80K amid lower trading volume and rising exchange reserves, signaling cautious market sentiment.

Bitcoin's price dropped to around $80,494, down 1.26%, alongside a 14.11% decline in trading volume, indicating weaker market participation. Despite increased network activity and a slight rise in Bitcoin's market dominance, sentiment remained neutra...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App